AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
| PLL | TEST ------- Piedmont Lithium Reports Q1 2025 Results | PRICE SENSITIVE | 08/05/25 | |
| PLL | Piedmont Announces Positive Initial Metallurgical Results | PRICE SENSITIVE | 09/04/18 | |
| PLL | Further High Grade Lithium Identified During Drilling | PRICE SENSITIVE | 04/04/18 | |
| PLL | Piedmont Continues to Define High Grade Lithium | PRICE SENSITIVE | 15/03/18 | |
| PLL | Piedmont Continues to Expand its First Mover Land Position | PRICE SENSITIVE | 06/03/18 | |
| PLL TEST ------- Piedmont Lithium Reports Q1 2025 Results | |||
| 08/05/25 | PRICE SENSITIVE | ||
| PLL Piedmont Announces Positive Initial Metallurgical Results | |||
| 09/04/18 | PRICE SENSITIVE | ||
| PLL Further High Grade Lithium Identified During Drilling | |||
| 04/04/18 | PRICE SENSITIVE | ||
| PLL Piedmont Continues to Define High Grade Lithium | |||
| 15/03/18 | PRICE SENSITIVE | ||
| PLL Piedmont Continues to Expand its First Mover Land Position | |||
| 06/03/18 | PRICE SENSITIVE | ||
